Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-03-03
DOI
https://doi.org/10.3389/fonc.2026.1815252
Primary Topic
Cancer Mechanisms and Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Weimin Cai, Zhijia Tang, Xia Guo, Yuhong Zhou et al.
Frontiers in Oncology
Cancer Mechanisms and Therapy
article

Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

Weimin Cai, Zhijia Tang, Xia Guo, Yuhong Zhou, Jun Zhang
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 16
Fudan University (CN), Zhongshan Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 37%
Cancer Mechanisms and Therapy
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene — Weimin Cai, Zhijia Tang, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS